Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer.
Kaelin WG Jr.
J Clin Invest. 2022 Sep 15;132(18):e162480. doi: 10.1172/JCI162480.
Resistant Hypertension: Diagnosis and Management.
Nagarajan N, Jalal D.
Adv Chronic Kidney Dis. 2019 Mar;26(2):99-109. doi: 10.1053/j.ackd.2019.03.002.
Secondary Hypertension Overview and Workup for the Primary Care Physician.
Turner JM, Dmitriev M.
Med Clin North Am. 2023 Jul;107(4):739-747. doi: 10.1016/j.mcna.2023.03.010. Epub 2023 Apr 18.
Hypertension in a Patient With Polycystic Kidney Disease Complicated by Concomitant Pheochromocytoma.
Ameti A, Kopp PA, Pitteloud N, Wuerzner G, Grouzmann E, Matter M, Lamine F, Phan O.
AACE Clin Case Rep. 2024 Apr 13;10(4):136-139. doi: 10.1016/j.aace.2024.04.001. eCollection 2024 Jul-Aug.
Enhanced Chronic Inflammation and Increased Branched-Chain Amino Acids in Adrenal Disorders: A Cross-Sectional Study.
Kittithaworn AA, Dogra P, Saini J, Gruppen EG, Atkinson E, Achenbach S, Yu K, Thangamuthu K, Connelly MA, Dullaart RPF, Bancos I.
J Clin Endocrinol Metab. 2025 Jan 21;110(2):e330-e338. doi: 10.1210/clinem/dgae204.
Catecholamine physiology and its implications in patients with COVID-19.
Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K.
Lancet Diabetes Endocrinol. 2020 Dec;8(12):978-986. doi: 10.1016/S2213-8587(20)30342-9. Epub 2020 Oct 28.
Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
Grigoryan S, Nhan W, Zhang L, Urban C, Zhao L, Turcu AF.
J Clin Endocrinol Metab. 2023 May 17;108(6):e343-e349. doi: 10.1210/clinem/dgac701.
Characterization and treatment of resistant hypertension.
Pisoni R, Ahmed MI, Calhoun DA.
Curr Cardiol Rep. 2009 Nov;11(6):407-13. doi: 10.1007/s11886-009-0059-z.
[Hypotension from endocrine origin].
Vantyghem MC, Douillard C, Balavoine AS.
Presse Med. 2012 Nov;41(11):1137-50. doi: 10.1016/j.lpm.2012.03.023. Epub 2012 Sep 10.
Medullary thyroid carcinoma and calcitonin.
Emmertsen K.
Dan Med Bull. 1985 Mar;32(1):1-28.
